Production of a Soluble Recombinant Antibody Fragment against MMP9 Using


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
18 Sep 2021
Historique:
received: 19 08 2021
revised: 13 09 2021
accepted: 16 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 30 9 2021
Statut: epublish

Résumé

Matrix metalloproteinase 9 (MMP9) is involved in several aspects of the pathology of cancer, including invasion, metastasis, and angiogenesis. In this study, we expressed a recombinant scFv-type anti-MMP9 antibody in soluble form using

Identifiants

pubmed: 34577904
pii: medicina57090981
doi: 10.3390/medicina57090981
pmc: PMC8468072
pii:
doi:

Substances chimiques

Immunoglobulin Fragments 0
Immunoglobulin Variable Region 0
Recombinant Proteins 0
MMP9 protein, human EC 3.4.24.35
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NRF grant funded by the Korean government
ID : NRF-2020R1I1A307411712
Organisme : WISET grant funded by the Ministry of Science and ICT(MSIT) under the Program for Returners into R&D
ID : 2020-24
Organisme : Real National R&D Challenge Program grant funded by the Korea Institute of Human Resources Development in Science & Technology
ID : 202101250001

Références

Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1182-92
pubmed: 12077439
Methods Mol Biol. 2009;562:215-24
pubmed: 19554299
Amino Acids. 2011 Jul;41(2):271-90
pubmed: 20640864
MAbs. 2010 Jan-Feb;2(1):77-83
pubmed: 20093855
Crit Rev Biochem Mol Biol. 2002 Dec;37(6):375-536
pubmed: 12540195
Oncotarget. 2014 May 15;5(9):2736-49
pubmed: 24811362
J Biol Chem. 2017 Apr 21;292(16):6810-6820
pubmed: 28235803
BMC Cardiovasc Disord. 2020 May 19;20(1):232
pubmed: 32429880
J Immunol Methods. 1998 Jul 1;216(1-2):165-81
pubmed: 9760222
Sensors (Basel). 2018 Sep 27;18(10):
pubmed: 30262739
Biotechnol Lett. 2003 Sep;25(17):1385-95
pubmed: 14514038
PLoS One. 2015 May 11;10(5):e0127063
pubmed: 25961845
Microb Cell Fact. 2005 Jan 04;4(1):1
pubmed: 15629064
Int J Cancer. 2000 Aug 1;87(3):336-42
pubmed: 10897037
Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72
pubmed: 23547785
MAbs. 2011 May-Jun;3(3):253-63
pubmed: 21487244
Biosens Bioelectron. 2016 Nov 15;85:32-45
pubmed: 27155114
Front Microbiol. 2014 Apr 17;5:172
pubmed: 24860555
Bioconjug Chem. 2019 Mar 20;30(3):800-807
pubmed: 30649877
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82
pubmed: 2164689
Eur J Orthod. 2013 Oct;35(5):644-51
pubmed: 22987319
FEBS J. 2011 Jan;278(1):16-27
pubmed: 21087457
Sci Rep. 2019 Nov 14;9(1):16850
pubmed: 31727948
Clin Cancer Res. 2018 Aug 15;24(16):3829-3837
pubmed: 29691300
Molecules. 2019 Jun 18;24(12):
pubmed: 31216704

Auteurs

Chang-Hun Yeom (CH)

Department of Biological and Chemical Engineering, Hongik University, Sejong 30016, Korea.

Hee-Jin Jeong (HJ)

Department of Biological and Chemical Engineering, Hongik University, Sejong 30016, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH